Cytoskeleton-Associated Protein 4 (CKAP4) (Middle Region) Peptide
Quick Overview for Cytoskeleton-Associated Protein 4 (CKAP4) (Middle Region) Peptide (ABIN975006)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CKAP4 antibody (Catalog #: ARP46790_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CKAP4 (Cytoskeleton-Associated Protein 4 (CKAP4))
-
Background
-
CKAP4/p63 is a substrate of DHHC2, a putative tumor suppressor. CK MNF116 and p63 were useful in identifying squamous cell carcinomas with single cell infiltration. Those results suggested a role of CKAP4/p63 in tumor.
Alias Symbols: CLIMP-63, ERGIC-63, MGC99554, p63
Protein Interaction Partner: ASCC2,PLAT,ASCC2,USP50
Protein Size: 602 -
Molecular Weight
- 66 kDa
-
Gene ID
- 10970
-
NCBI Accession
- NM_006825, NP_006816
-
UniProt
- Q07065
Target
-